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Disulfide loop cleavage of 
Legionella pneumophila PlaA boosts 
lysophospholipase A activity
Christina Lang, Miriam Hiller & Antje Flieger
L. pneumophila, an important facultative intracellular bacterium, infects the human lung and 
environmental protozoa. At least fifteen phospholipases A (PLA) are encoded in its genome. Three of 
which, namely PlaA, PlaC, and PlaD, belong to the GDSL lipase family abundant in bacteria and higher 
plants. PlaA is a lysophospholipase A (LPLA) that destabilizes the phagosomal membrane in absence 
of a protective factor. PlaC shows PLA and glycerophospholipid: cholesterol acyltransferase (GCAT) 
activities which are activated by zinc metalloproteinase ProA via cleavage of a disulphide loop. In this 
work, we compared GDSL enzyme activities, their secretion, and activation of PlaA. We found that PlaA 
majorly contributed to LPLA, PlaC to PLA, and both substrate-dependently to GCAT activity. Western 
blotting revealed that PlaA and PlaC are type II-secreted and both processed by ProA. Interestingly, 
ProA steeply increased LPLA but diminished GCAT activity of PlaA. Deletion of 20 amino acids within 
a predicted disulfide loop of PlaA had the same effect. In summary, we propose a model by which ProA 
processes PlaA via disulfide loop cleavage leading to a steep increase in LPLA activity. Our results help 
to further characterize the L. pneumophila GDSL hydrolases, particularly PlaA, an enzyme acting in the 
Legionella-containing phagosome.
Legionella pneumophila is an important facultative intracellular bacterium, with protozoa as its natural host. It 
can also survive within biofilms in technical water systems. In humans, the bacterium causes severe damage of 
the lung, which may lead to pneumonia and fatalities. A steady increase of Legionnaires’ pneumonia has been 
noted in Europe during the last years resulting in about 7000 cases including more than 500 deaths in 20141. 
Furthermore, outbreaks involving multitudes of cases have been frequently described2.
Phospholipases are important virulence factors of L. pneumophila, which can interfere with host cell pro-
cesses and shape infection outcome. They are abundant in L. pneumophila with at least 15 different phospholi-
pases A (PLAs), three phospholipases C, and one phospholipase D being encoded in the genome3–10. PLAs in L. 
pneumophila divide into three major groups, the patatin-like, the PlaB-like and the GDSL enzymes3,11. The latter 
are represented in many bacteria and also higher plants and include the following enzymatic spectrum: PLA, 
lysophospholipase A (LPLA), lipase, haemolytic, and glycerophospholipid: cholesterol acyltransferase (GCAT) 
activities12,13. One example is the Aeromonas salmonicida type II-secreted acyltransferase/PLA SatA, which is an 
extracellular lethal toxin for Atlantic salmon and active on fish erythrocytes14–18. Extracellular GCAT activity of 
SatA is triggered by the bacterial serine protease AspA. SatA can also be activated by trypsin, cleaving the toxin 
within a disulphide loop flanked by residues cysteine 225 and cysteine 28119,20. Another example is the Salmonella 
pathogenicity island 2 (SPI2) type III-secreted effector SseJ, which also exhibits acyltransferase and PLA activities 
following activation by the host cell small GTPase RhoA21–24. SseJ together with SifA, another SPI2 effector, have 
been shown to regulate dynamics and integrity of the Salmonella-containing compartment. In the absence of SifA, 
membrane integrity of the Salmonella-containing vacuole is lost and the bacteria are released into the cytosol. An 
additional knock out of sseJ reverts this effect24–27.
L. pneumophila possesses three GDSL enzymes, PlaA, PlaC, and PlaD, which share a similar putative catalytic 
triade. However, they differ in protein size, protein organisation, and predicted signal peptides, indicating that they 
might have different properties and functions (Fig. 1)3. While the activity of PlaD has not yet been comprehensively 
defined, PlaA and PlaC indeed show distinct activities. PlaC predominantly exhibits GCAT and PLA activities28,29. 
Analysis of single GDSL enzyme knock out mutants showed that PlaC represents the only enzyme in L. pneumophila 
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transferring palmitic acid from diacaylphospholipids to cholesterol and ergosterol. The L. pneumophila zinc metal-
loproteinase ProA highly promotes PlaC-derived GCAT and PLA activities. It directly processes a disulphide loop 
region in PlaC leading to enzyme activation. These data suggest that a disulphide loop inhibits PlaC GCAT activity 
until the protein is exported and ProA-activated. The three putative catalytic amino acids, serine 37, aspartate 398, 
and histidine 401, proved to be essential for all PlaC-associated activities30. PlaA is the major secreted LPLA29,31,32. 
PlaA, and to some extent PlaC, transfer the short chain fatty acid, propionic acid, to cholesterol and ergosterol30. 
However, whether an activation procedure supports PlaA activity has not been described.
Loss of specific activities in secretion mutants and the presence of a signal peptide indicate that PlaA and PlaC 
are secreted by the L. pneumophila type II secretion system Lsp. PlaC is further found in outer membrane vesicles 
(OMVs)28,32–35. Both OMVs and the type II-secreted protease ProA have been detected within the lumen of the 
Legionella-containing vacuole (LCV)34,36 and an influence of PlaA on the phagosomal membrane has been shown 
before. Specifically, PlaA promotes membrane destabilization of the LCV in the absence of the type IVB-secreted 
effector SdhA, resulting in the activation of host cell death pathway37. PlaA and PlaC have the potential to act 
on phagosomal lipids and further modify cholesterol-rich regions within mammalian cells, as it was previously 
shown for SseJ, a GCAT of Salmonella enterica. Therefore, L. pneumophila PlaA and PlaC may influence LCV 
receptor presentation, membrane organization and stability21,38.
Here, we aimed to characterize enzyme activity and a possible mode of activation for L. pneumophila PlaA. In 
a first step, we compared the contribution of the three L. pneumophila GDSL enzymes to bacterial PLA/LPLA and 
GCAT activities and their export into the bacterial culture supernatant. Then, we addressed the question whether 
ProA has an impact on enzyme activity of PlaA, as it was shown for PlaC. Indeed, ProA is an important factor in 
the processing of PlaA via disulphide loop cleavage thereby modulating its enzymatic activity.
Results
PlaA majorly contributes to LPLA activity, PlaC to PLA activity, and both substrate-dependently 
to GCAT activity of L. pneumophila culture supernatant. To compare the contribution of the GDSL 
enzymes to different lipolytic activities in L. pneumophila, we analyzed single mutants and a triple mutant for fatty 
acid release and sterol ester formation after incubation with different lipid substrates (Fig. 2A). Figure 2B shows 
amounts of free fatty acids (FFA) liberated by culture supernatants where phosphatidylglycerol (PG) and phosphati-
dylcholine (PC) hydrolysis reveals PLA, lysophosphatidylglycerol (LPG) and lysophosphatidylcholine (LPC) LPLA 
and monoacylglycerol (MPG) lipase activities. As expected, wild type bacteria showed highest levels of activities 
towards all substrates. Reductions in secreted activities were noted for the plaA, the plaC and the plaACD triple 
mutant but not for the plaD mutant. Specifically, the plaA mutant was strongly reduced in LPG, LPC, and to some 
extent in MPG hydrolysis confirming major LPLA activity of PlaA. The plaC mutant showed reductions in PG and 
PC hydrolysis indicating contribution of PlaC to PLA activity. The plaACD mutant revealed lowest activities repre-
senting the additive lack of PlaA and PlaC. Nevertheless, hydrolysis of PG, PC and LPG was observed for the plaACD 
mutant supernatant revealing the presence of further secreted PLA/LPLA(s) in addition to the GDSL enzymes. PlaD 
under these conditions had no contribution to the secreted lipolytic activities (Fig. 2B). We next asked whether the 
three enzymes might have a role in cell-associated activities. However, no decreased activities of the mutants were 
found suggesting that cell-associated activities were independent of PlaA, PlaC or PlaD (Fig. 2C).
Further, we analyzed GCAT activity of L. pneumophila culture supernatants. Here we confirmed the importance 
of PlaC for transfer of fatty acids from PC to cholesterol, represented by the lack of cholesterolpalmitate (CP) and –
propionate (CPP) generation by the plaC and plaACD mutants (Fig. 2D). When, however, LPC was used as a donor 
of palmitic acid, the wild type did not develop CP at all, indicating that under those conditions palmitic acid transfer 
is not favored by the GDSL enzymes. Interestingly, only the plaA mutant formed CP, implying that in the absence of 
PlaA, another enzyme, such as PlaC, may use LPC (which here was not reacted by PlaA) as a donor for palmitic acid 
(Fig. 2E). Wild type and the single mutants produced CPP, albeit with different efficiencies. Among the single mutants, 
the plaA mutant displayed the greatest reduction in the generation of CPP confirming a previous observation that PlaA 
contributes significantly to the CPP production in L. pneumophila30. Neither CP nor CPP could be detected with the 
culture supernatant of the plaACD mutant, displaying exclusive contribution of the three GDSL enzymes to GCAT 
Figure 1. Schematic overview of L. pneumophila GDSL hydrolases PlaA, PlaC, and PlaD. Localization of 
putative catalytic amino acids of L. pneumophila PlaA, PlaC and PlaD as well as predicted signal peptides 
(SignalP 4.1 Server) and disulphide bonds (DiANNA 1.1 web server) of PlaA and PlaC are depicted. 
Abbreviations: SP—predicted signal peptide, -SP—variant after cleavage of signal peptide, aa—amino acid(s), 
S-S bridge—predicted disulphide bond, aa19-242 and aa25-342—PlaA- and PlaC-derived variants comprising 
amino acids 19 till 242 and 25 till 342, respectively, after loss of signal peptide and loss of C-terminal region after 
disulphide loop cleavage and reduction of disulphide bond.
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Figure 2. PlaA majorly contributes to LPLA, PlaC to PLA, and both substrate-dependently to GCAT activity 
of L. pneumophila culture supernatant. (A) Schematic overview of lipolytic activities of PlaA (PLA, LPLA, 
GCAT). Displayed are cleavage sites in phospholipids and monoglycerides as well as reaction products. R1 
and R2 denote long chain fatty acid residues and X the polar headgroup. PLA and LPLA activities of culture 
supernatans (B) and cell lysates (C) from L. pneumophila Corby wild type and different knock out mutants 
(plaA−, plaC−, plaD− and plaACD−) were determined via quantification of FFA after incubation for 16 h with 
the indicated lipids at 37 °C. Formation of different cholesterol esters by L. pneumophila culture supernatants 
was studied after incubation for 16 h at 37 °C with PC (D) and LPC (E) followed by lipid extraction and TLC. 
The results represent the means and standard deviations of duplicate reactions (B,C). All results shown are 
representative for at least two additional experiments. CP, cholesterol palmitate; CB, cholesterol butyrate; CPP, 
cholesterol propionate; FFA, free fatty acids; C, cholesterol.
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activity (Fig. 2D,E). To summarize, PlaA and PlaC activities in L. pneumophila culture supernatant showed clear differ-
ences. PlaA contributed majorly to LPLA activity and acyl transfer from lysophospholipids to cholesterol whereas PlaC 
revealed PLA activity and acyl transfer from diacylphospholipids to cholesterol.
PlaA and PlaC are type II-secreted and zinc metalloproteinase ProA-processed. PlaA and PlaD 
were recombinantly expressed, purified, and polyclonal antibodies were raised as described earlier for PlaC30. 
Previously, secretion types of PlaA and PlaC have been deduced from the lack of enzymatic activities in the cul-
ture supernatants of defined secretion mutants28,32. The generation of specific antibodies provided us with a tool to 
directly detect the proteins in different bacterial fractions, and assess their secretion path and processing. To that 
end, we prepared culture supernatants and cell lysates from wild type, different secretion mutants and the proA 
mutant. After Western blot analysis, the pattern observed was quite similar for PlaA and PlaC. Both proteins were 
found in the supernatant of all strains but not in the lspDE mutant and the negative control (plaACD-), confirm-
ing that PlaA and PlaC export is type II secretion system-dependent (Fig. 3). While PlaA in the supernatants was 
mostly present as a ~26–28 kDa protein, PlaC had a size of about 36 kDa. The latter represents the processed and 
ProA-activated form of PlaC30. Consequently, a larger protein version of about 47 kDa representing unprocessed 
PlaC could be detected in the supernatant of the proA mutant (Fig. 3, Fig. 1). PlaA was also present in a higher 
molecular form of ~34 kDa in the proA mutant supernatant suggesting its processing by ProA (Fig. 3, Fig. 1). 
Interestingly, PlaA and PlaC were not detected in substantial amounts in cell lysates of the different strains unless 
their secretion was prevented by an lspDE knock out (Fig. 3). On the contrary, PlaD was only detected in the 
cell lysates, except in the plaACD mutant, but not in culture supernatants (Fig. 3). In summary, we here provide 
evidence that PlaA and PlaC are Lsp type II-secreted and ProA-processed whereas PlaD remains cell associated.
rPlaA shows LPLA, lipase, and GCAT activities which depend on the individual members of 
the catalytic triade: serine 30, aspartate 279, and histidine 282. For further analysis of PlaA, the 
protein was recombinantly expressed in E. coli and either the purified protein or cell lysates were used for lipolysis 
assays. As shown in Fig. 4A, rPlaA possessed lipase and LPLA activities, the latter especially towards LPG and 
LPC. A site directed mutation, affecting serine 30 in the GDSL motif, as well as the other two potential members 
of the catalytic triade, aspartate 279 and histidine 282, reduced LPLA or lipase activities to background levels 
highlighting their importance in catalysis (Fig. 4A,B). GCAT activity of rPlaA was found for the transfer of short 
chain fatty acids (generation of CPP) and palmitic acid (generation of CP) with MPG and lysophospholipids as 
donors (Fig. 4C,D). The formation of CP was surprising because PlaA-dependent CP development was not found 
for L. pneumophila culture supernatants (Fig. 2D,E). As expected the catalytic site mutants did not exhibit GCAT 
activity (Fig. 4C,D). In conclusion, rPlaA shows LPLA, lipase, and GCAT activities dependent on a serine 30, 
aspartate 279, histidine 282 catalytic triade.
Figure 3. PlaA and PlaC are secreted via the type II secretion system Lsp and processed by the zinc 
metalloproteinase ProA. 10-fold concentrated supernatants (upper panel) and cell lysates (lower panel) of L. 
pneumophila Corby or JR32 wild types or isogenic mutant strains were applied to reducing SDS-PAGE, Western 
blot analysis and detection with α-PlaA, α-PlaC, and α-PlaD antibodies. Results are representative for at least 
two additional experiments. Molecular weight standards (M) are shown on the left side of each panel in kDa. 
Blot images were slightly cropped from all sides. α-PlaA and α-PlaC cell lysates blot images were vertically 
sliced to adjust the lanes to the corresponding supernatant blot image. Full length blots are presented in 
Supplementary Fig. S1. (-SP = without signal peptide; p = processed).
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Zinc metalloproteinase ProA boosts LPLA activity of rPlaA but diminishes GCAT activity trans-
ferring palmitic acid. PlaA is C-terminally processed by ProA. Next we were interested if the zinc 
metalloproteinase ProA of L. pneumophila has an impact on PlaA activity as it has been previously demonstrated 
for PlaC, where especially GCAT activity increases after ProA treatment30. To test for a ProA-dependent effect 
on PlaA activity we initially used culture supernatant of an L. pneumophila plaACD mutant containing ProA but 
lacking GDSL enzyme-derived activities in the lipid hydrolysis samples. Indeed, a steep increase in LPLA activ-
ity with LPG and LPC as substrates was detected when the supernatant was added to the reaction mixture with 
purified rPlaA. In contrast, no substantial activity was observed with the purified S30N-mutated rPlaA (Fig. 5A). 
Of note, a slight increase in PG hydrolysis was measured in the case of incubation of rPlaA and rPlaAS30N with 
the culture supernatant suggesting the presence of a non-GDSL PLA in the supernatant of the plaACD mutant 
(Fig. 5A).
Western Blot analysis indicated processing of PlaA by ProA (Fig. 3) and therefore, we analyzed whether rProA 
also acts on rPlaA. Indeed, rPlaA but not rPlaAS30N showed a substantial increase in LPLA activity when incu-
bated with rProA (Fig. 5B). In contrast to the earlier described increase in PlaC activity upon ProA activation, 
no enhancement of GCAT activity was observed for rPlaA treated with rProA. Instead, rProA addition resulted 
in loss of palmitic acid transfer from LPC to cholesterol (i.e. no generation of CP) by rPlaA (Fig. 5C). This might 
explain why no explicit PlaA-derived GCAT activity transferring palmitic acid from lysophospholipids was 
observed in the L. pneumophila wild type in the experiments presented above (Fig. 2D,E). In contrast, transfer of 
short chain fatty acids was found independent of ProA (Fig. 5C).
To verify processing of PlaA by ProA, we incubated rPlaA with rProA followed by Western blotting with a 
PlaA-specific antibody or another antibody directed towards the N-terminal Strep tag. In both cases, rPlaA was 
found to be processed after 10 minutes incubation, characterized by the appearance of an ~26–28 kDa protein 
band (Fig. 5D,E), which corresponds to the size of PlaA in the above analyzed L. pneumophila strains, except the 
proA mutant (Fig. 3). Cleaved rPlaA could still be detected with the anti-Strep antibody suggesting that PlaA is 
processed on its C-terminal side (Fig. 5D,E).
Figure 4. rPlaA shows LPLA, lipase, and GCAT activities which depend on the individual members of the 
catalytic triade serine 30, aspartate 279 and histidine 282. PLA and LPLA activites of rPlaA and catalytic 
site mutants were determined via quantification of FFA after incubation for 3 h with the indicated lipids 
at 37 °C (A,B). Formation of different cholesterol esters was studied after 16 h incubation at 37 °C with the 
indicated lipids, followed by lipid extraction and TLC (C,D). Reactions were performed with recombinant 
purified protein (A,C) or with cell lysates (B,D) of E. coli clones expressing PlaA, PlaA S30N, PlaA D279N, 
or PlaA H282N [BL21(pGP172 plaA = pCL119), BL21(pGP172 plaA S30N = pCL121), BL21(pGP172 plaA 
D279N = pCL122) and BL21(pGP172 plaA H282N = pCL123)]. The results represent the means and standard 
deviations of duplicate reactions (A,B). All results shown are representative for at least two additional 
experiments. CP, cholesterol palmitate; CB, cholesterol butyrate; CPP, cholesterol propionate; FFA, free fatty 
acids; C, cholesterol; A, PlaA; AS, PlaA S30N; Std, standard.
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An incubation time extending 1 h resulted in stable detection of the ~26–28 kDa fragment with the 
PlaA-specific antibody. On the contrary, the Strep-PlaA version was no longer detectable under these conditions 
(Fig. 5D,E). These data suggest further processing of rPlaA at the N-terminus. However, no second substantial 
molecular shift of rPlaA could be observed with the PlaA antibody indicating that N-terminal cleavage of rPlaA 
is likely a minor procession (Fig. 5D,E). After 5 h of incubation of rPlaA without rProA further degradation of 
the protein from the C-terminal side occurred (Fig. 5D,E). As a conclusion, we showed that PlaA LPLA activity is 
steeply increased but GCAT activity is diminished by ProA which processes PlaA at its C-terminus.
Deletion of 20 amino acids in a predicted disulphide loop of rPlaA results in boosted LPLA activ-
ity but diminished GCAT activity transferring palmitic acid. L. pneumophila PlaC GCAT is activated 
through truncation of a disulphide loop by ProA30. Like PlaC, PlaA contains a predicted disulphide loop, which 
in this case consists of 28 amino acids (Fig. 1). Indeed, the ~26–28 kDa PlaA fragment observed in wild type L. 
pneumophila culture supernatant and after treatment of rPlaA with rProA nicely matches a protein, which is 
cleaved within the disulphide loop region (Figs 1, 3 and 5D,E). After reducing SDS-PAGE, the disulphide bond 
would be opened and the cleaved C-terminal part would be released corresponding to a ~ 28 kDa fragment visible 
after Western blotting. A truncated disulphide loop in PlaC has been shown to render the protein more active, 
especially with respect to GCAT activity independently of ProA30.
Therefore, we deleted 20 amino acids from the disulphide loop of PlaA and analyzed lipolytic activities of 
purified rPlaA versus rPlaAdel248–267. Indeed, lipase and LPLA activities of the loop deletion protein increased 
steeply compared to full length rPlaA (Fig. 6A). When culture supernatant of the L. pneumophila plaACD mutant 
or rProA was added to the preparations, the degree of activation was not further enhanced indicating that in the 
absence of the disulphide loop region, PlaA LPLA activity is independent from ProA-based activation (Fig. 6B,C). 
In accordance with the results above and in contrast to steep activation of LPLA activity, GCAT activity was not 
Figure 5. Addition of ProA increases LPLA and diminishes GCAT activity of rPlaA transferring palmitic acid. 
PLA and LPLA activities of purified, recombinant PlaA versus catalytic inactive PlaA S30N were determined via 
quantification of FFA after incubation for 3 h (A,B) with the indicated lipids at 37 °C without or with addition 
of either L. pneumophila plaACD− culture supernatant (A) or purified, recombinant ProA (B). Formation of 
different cholesterol esters by recombinant PlaA and PlaA S30N without or with addition of ProA was studied 
after 16 h incubation at 37 °C with the indicated lipids, followed by lipid extraction and TLC (C). Processing 
of PlaA by ProA was analyzed by anti-PlaA (D) anti-Strep (E) Western blot after incubation of rPlaA without 
or with rProA for indicated time points at 37 °C. Molecular weight standards (M) are shown on the left side of 
each panel in kDa. Blot images were cropped from all sides. Full length blots are presented in Supplementary 
Fig. S2. The results represent the means and standard deviations of duplicate reactions (A,B). All results shown 
are representative for at least two additional experiments. CP, cholesterol palmitate; CB, cholesterol butyrate; 
CPP, cholesterol propionate; FFA, free fatty acids; C, cholesterol; A, PlaA; AS, PlaA S30N; sup, L. pneumophila 
plaACD− culture supernatant.
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detectable for the loop truncation protein, showing that GCAT activity of PlaA is diminished by loop deletion 
(Fig. 6D). For the loop deletion protein no substantial processing after ProA addition, as it was observed for rPlaA 
(Fig. 5D,E), was detected with the PlaA or Strep tag antibodies. However, a limited N-terminal processing releas-
ing the N-terminal Strep-Tag was observed (Fig. 6E,F). This means that deletion of the disulphide loop leads to 
comparable activities as seen for full length PlaA processed by ProA. We therefore localized the ProA cleavage site 
within PlaA to the amino acid region between aspartate 248 and leucine 267.
PlaA is cleaved by ProA between glutamate 266 and leucine 267. Mass spectrometry analysis of 
rPlaA incubated with rProA indeed confirmed that PlaA is cleaved by ProA between cysteine 243 and cysteine 
272. The peptides identified indicated that all potential cleavage sites are within the disulphide loop region. The 
most probable ProA-cleavage site within PlaA was in front of leucine 267 because the respective peptide displayed 
the highest intensity (Fig. 7, Table. S1). Mutagenesis of glutamate 266 and leucine 267 to asparagine was not 
sufficient to prevent the cleavage of PlaA by ProA (Fig. S4). This indicates that also less preferential sites may be 
cleaved by ProA which then also results in protein activation.
Figure 6. Deletion of 20 amino acids in a predicted disulphide loop of rPlaA results in increased LPLA activity 
and diminished GCAT activity transferring palmitic acid. PLA and LPLA activities of purified, recombinant 
PlaA Del. 248-67 versus catalytic inactive PlaA S30N Del. 248-67 were determined via quantification of FFA 
after incubation for 3 h (A,B,C) with the indicated lipids at 37 °C without (A) or with addition of either L. 
pneumophila plaACD− culture supernatant (B) or purified, recombinant ProA (C). Formation of different 
cholesterol esters by recombinant PlaA Del. 248-67 and PlaA S30N Del. 248 -67 without or with addition of 
ProA was studied after 16 h incubation at 37 °C with the indicated lipids, followed by lipid extraction and TLC 
(D). Processing of PlaA Del. 248-67 by ProA was analyzed by anti-PlaA (E) and anti-Strep (F) Western blot after 
incubation of rPlaA Del. 248-67 without or with rProA for indicated time points at 37 °C. Molecular weight 
standards (M) are shown on the left side of each panel in kDa. Blot images were cropped from all sides. Full 
length blots are presented in Supplementary Fig. S3. Results shown in Fig. 6D were from the same experiment as 
shown in Fig. 5C but were run on separate TLC plates. The results represent the means and standard deviations 
of duplicate reactions (A–C). All results shown are representative for at least two additional experiments. CP, 
cholesterol palmitate; CB, cholesterol butyrate; CPP, cholesterol propionate; FFA, free fatty acids; C, cholesterol; 
A, PlaA Del. 248-67; AS, PlaA S30N Del. 248-67; sup, plaACD− L. pneumophila culture supernatant.
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Discussion
We previously described that a GDSL enzyme of L. pneumophila, PlaC, is activated by a ProA-dependent disul-
phide loop cleavage. After cleavage, the two fragments of the protein, each containing catalytic essential amino 
acids, are kept together by a disulphide bond (Fig. 1). PlaC cleavage by ProA predominantly activates GCAT and 
also PLA activity of the enzyme. Mutants of PlaC where the disulphide loop was shortened from 44 to 31, 24, 22, 
or 6 amino acids show ProA-independent activation of GCAT, suggesting a loop-mediated enzyme inhibition/
activation mechanism. This ProA-mediated regulation might serve to protect the bacterium from a potential 
harmful activity of PlaC within the cell30.
A variety of enzymes with distinct activities using similar but not identical activation strategies have been 
described before. For example, Pseudomonas exotoxin A is a ADP-ribosylase, which is activated by proteolytic 
cleavage within a disulphide loop and subsequent reduction of the disulphide bridge, thereby releasing the active 
domain39,40. Another example is Shiga toxin of enterohemorrhagic E. coli, where the C-terminal region of subunit 
A contains a disulphide loop with the trypsin and furin recognition sequence R-V-A-R. Cleavage results in enzy-
matically active N-glycosidase and disulphide bond linked A1 and A2 fragments41,42.
In the case of PlaA, a ProA-dependent activation via disulphide loop processing was found and we propose 
the following model of PlaA activation. PlaA and ProA are both present as preproenzymes within the cytoplasm. 
Both are transported through the inner bacterial membrane via the Sec system and concomitant signal peptide 
cleavage. In the periplasm, a disulphide bond may be formed within PlaA (internal preform). Cell-associated 
quantity and activity of PlaA are very low (Figs 3 and 2C) compared to those in the external space suggesting 
fast export of the protein. After subsequent export of PlaA and ProA via the type II secretion system Lsp, ProA 
acquires its mature form via autoactivation by means of N-terminal propeptide cleavage43. PlaA (external pre-
form) is then processed by ProA resulting in the external mature form of PlaA with increased LPLA activity and 
lost GCAT activity for transfer of palmitic acid (Fig. 8).
LPLA activity steeply increased when PlaA was processed by ProA or alternatively when the disulphide loop 
was shortened from 28 to 8 amino acids. We previously described that the loop region of PlaC shared substantial 
homology to PlaC-like enzymes from Legionella but not to the corresponding PlaA-like enzymes30. Similarly, 
the loop region in PlaA is only conserved in PlaA-like enzymes of L. pneumophila. Mass spectrometry analysis 
revealed that PlaA is cleaved by ProA within the loop region, but mutagenesis of the most probable cleavage site 
was not sufficient to prevent the digestion by ProA. The same was observed for PlaC, where several ProA-cleavage 
sites were found within the disulphide loop region, but mutagenesis studies of potential target sites indicated that 
the protease either is not very selective or that structural features are important30.
Although the proteolytic processing is very similar between PlaC and PlaA they are differentially reg-
ulated by ProA. Unprocessed PlaA possesses LPLA activity and has specific GCAT activity, only accepting 
Figure 7. Overview of semi-tryptic peptides of PlaA cleaved by ProA identified by mass spectrometry. The 
upper part displays a fragment of the PlaA protein sequence (amino acid 240 to 290). The heat map on the right 
site visualizes the intensity values of the peptides found cleaved by ProA, whereby brighter red represents a 
higher intensity. All potential cleavage sites were detected within the disulfide loop region between cysteine 243 
and cysteine 272. The most probable ProA-cleavage site within PlaA is in front of leucine 267 indicated by the 
big grey arrow. Less probable cleavage sites are highlighted by a smaller grey arrow. Small black arrows indicate 
trypsin cleavage sites.
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lysophospholipids as fatty acid donors. Unprocessed PlaC has PLA activity and corresponding GCAT activity, 
which transfers palmitic acid and short chain fatty acids from diacylphospholipids to cholesterol. While PLA and 
GCAT activity of PlaC are both enhanced by proteolytic processing, PlaA processing leads to enhanced LPLA 
activity but diminished GCAT activity. We conclude that external proPlaA may predominantly act as GCAT at 
earlier time points of growth prior to ProA secretion. However, at later time points after ProA-mediated process-
ing, PlaA shifts its activity to a very potent LPLA (Figure 8). Activated PlaA may then contribute to phagosomal 
membrane disintegration as described before when the protective type IVB secreted Dot/Icm effector SdhA is 
not present37.
Most interestingly, the type IVB secreted effector SdhA counteracts LCV disintegration by type II-secreted 
PlaA37. The mechanism by which this is achieved and whether the interaction is direct or indirect is not known so 
far. Nevertheless, keeping the vacuole membrane intact is a very important process to prevent immune detection of 
L. pneumophila37,44. It is possible that PlaA acts from the inside of the phagosome whereas the Dot/Icm injected SdhA 
rather acts from the outside. One can hypothesize that PlaA, although not able to drive bacterial exit from the LCV in 
the presence of SdhA, prepares the membrane for facilitated exit at a later time point under the influence of additional 
factors. Further, PlaA might help to modify the LCV membrane in a way that it is more prone to fuse with other lipid 
compartments or may facilitate expansion of the phagosomal membrane when the bacteria are replicating.
But the question remains: How does an LPLA activity, directed towards lysophospholipids but not diacylphos-
pholipids, disintegrate the LCV membrane? The type II-secreted enzyme ProA was previously found in the LCV 
lumen36; therefore it is possible that other type II secreted enzymes, such as PlaA or PlaC, localize to the same 
compartment. Provided that the LCV membrane resembles the membrane of the endoplasmic reticulum or the 
plasma membrane, its major lipid components would be PC, phosphatidylethanolamine, phosphatidylserine, and 
phosphatidylinositol45. In this case an LPLA alone should not substantially disintegrate the membrane of the com-
partment. Nevertheless, several conditions may facilitate such a process: specifically when 1) in addition to ProA 
another yet unknown activating factor switches LPLA to PLA activity, 2) the LCV contains a substantial amount 
of lysophospholipids or another yet not identified substrate of PlaA, and 3) PlaA acts together with another 
enzyme showing PLA activity. The latter point seems most plausible. PlaC or another currently not identified PLA 
could potentially catalyze the first step resulting in the release of a fatty acid from a diacylphospholipid thereby 
producing the lysophospholipid substrate for PlaA. PlaC was found in L. pneumophila OMVs but not PlaA34. If 
a twostep hydrolysis of the LCV membrane is conceivable by PlaC and PlaA, fusion of PlaC-containing OMVs 
might strongly promote the disintegration process34. PlaA may then take over the second step and hydrolyze the 
lysophospholipid and thereby may accelerate the process substantially. Furthermore, enhanced LPLA activity 
could be useful for the elimination of the signal transducer LPC46. LPC is known as a factor for enhancement 
Figure 8. Proposed model for export and ProA-dependent processing of PlaA. PlaA and ProA are present in 
a preproform within the cytoplasm. Both are transported through the inner bacterial membrane via the Sec 
system and concomitant signal peptide cleavage. In the periplasm, a disulphide bond may be formed within 
PlaA (internal preform). Quantities and PlaA-derived activity in association with the bacterial cell are very low 
(Figs 2C and 3) compared to those in the external space suggesting fast export of the protein. After subsequent 
export of PlaA and ProA via the type II secretion system Lsp, ProA acquires its mature form via autoactivation 
by means of N-terminal propeptide cleavage43. PlaA (external preform) is then processed by ProA resulting in 
the external mature form of PlaA with increased LPLA activity and lost GCAT activity for transfer of palmitic 
acid. IM, inner bacterial membrane; OM, outer bacterial membrane; LPS, lipopolysaccharide.
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of neutrophil bactericidal activity and can lead to reduced bacterial viability47,48. Lower LPC levels as a result of 
increased LPLA activity might therefore support bacterial survival and integrity.
Methods
Bacterial strains and growth conditions. L. pneumophila sg1 strain Corby was used for all experiments, 
including knock out mutant construction, as well as for recombinant gene expression in E. coli strains DH5α and 
BL21. The used strains are listed in Table 1 and were grown on buffered charcoal yeast extract (BCYE) agar and in 
buffered yeast extract (BYE) broth (both for Legionella), or on Luria Bertani (LB) agar and in LB broth (both for 
E. coli) as described previously28,49,50.
DNA techniques and sequence analysis. E. coli BL21 was used for the propagation of recombinant plas-
mid DNA with backbones of the following vectors: pGP17251 and pet28a(+) (Novagen). Genomic and plasmid 
DNA were prepared, amplified, and sequenced according to standard protocols. Primers were obtained from 
Eurofins MWG Operon. Restriction enzymes were purchased from New England Biolabs. Foreign DNA was 
introduced into E. coli strains by electroporation with a Life Technologies cell porator according to the manu-
facturer’s specifications as described earlier28. Nucleotide and translated protein sequences were analyzed using 
the Geneious 10.0.0552, the NCBI website (http://www.ncbi.nlm.nih.gov/), DiANNA 1.1 (http://clavius.bc.edu/~-
clotelab/DiANNA/), SignalP 4.1 (http://www.cbs.dtu.dk/services/SignalP/) and ExPASy (http://www.expasy.ch).
Cloning of L. pneumophila plaA and plaD into pGP172 for recombinant expression in E. coli. L. 
pneumophila Corby plaA (lpc1811) and plaD (lpc 0558) were cloned into the pGP172 vector resulting in pCL119 
and pSB2 (N-term. Strep-Tag). To create PlaA disulphide loop deletion mutant constructs, pCL119 was amplified 
with primers listed in Table 2 and ligated; resulting in pCL126. To introduce mutations into the plaA gene, the 
pCL119 vector was mutated by means of the QuikChange Site-Directed Mutagenesis Kit (Stratagene) with the 
primers listed in Table 2, resulting in pCL121-pCL123, pCL127 and pMH41.
L. pneumophila GDSL enzyme knock out mutant construction. Plasmids pER11 and pCL13, con-
taining the plaC and plaD genes, disrupted or partially replaced by a Gentr and Hygr cassette, respectively, were 
used to introduce Gentr and Hygr gene insertion mutation into the chromosome of strain L. pneumophila Corby 
plaA-mutant30 via allelic exchange. To generate pER11, L. pneumophila 130b plaC was cloned into the pGEM-Tez 
vector yielding in pBH128. After pBH1 restriction by means of HindIII and BamHI, the Gentr-gene cassette was 
Organism Mutation(s)/Plasmid Tags selection marker(s) Reference
L.pn. Corby wild type ----- 62
L.pn. Corby plaA knock out KmR 30
L.pn. Corby plaC knock out KmR 30
L.pn. Corby plaD knock out KmR 30
L.pn. Corby plaACD knock out KmR, HygR, GentR this study
L.pn. Corby proA knock out KmR 30
L.pn. Corby lspDE knock out KmR 32
L.pn. Corby lssB knock out KmR 63
L.pn. Corby fliA knock out KmR 64
L.pn. JR32 wild type ----- 65
L.pn. JR32 dotA knock out KmR 66
L.pn. JR32 dotB knock out KmR 65
L.pn. JR32 lvh knock out GentR 67
E. coli BL21 pCL119 = pGP172 plaACorby (-SP*) N-term. Strep-tag AmpR this study
E. coli BL21 pCL121 = pGP172 plaACorby S30N (-SP) N-term. Strep-tag AmpR this study
E. coli BL21 pCL122 = pGP172 plaACorby D279N (-SP) N-term. Strep-tag AmpR this study
E. coli BL21 pCL123 = pGP172 plaACorby H282N (-SP) N-term. Strep-tag AmpR this study
E. coli BL21 pCL126 = pGP172 plaACorby ΔAA248-67(-SP) N-term. Strep-tag AmpR this study
E. coli BL21 pCL127 = pGP172 plaACorby S30N ΔAA248-67 (-SP) N-term. Strep-tag AmpR this study
E. coli BL21 pMH41 = pGP172 plaACorby E266N L267N N-term. Strep-tag AmpR this study
E. coli BL21 pSB2 = pGP172 plaDCorby N-term. Strep-tag AmpR this study
E. coli BL21 pCL15 = pet28a(+) proACorby C-term. 6xHis-tag KmR 30
E. coli DH5α pCL7 = pBCKS PplaD plaDCorby CmR this study
E. coli DH5α pCL13 = pBCKS PplaD plaDCorby::HygR HygR, CmR this study
E. coli DH5α pBH1 = pGEMTez plaC130b AmpR 28
E. coli DH5α pER11 = pGEMTez plaC130b::GentR GentR, AmpR this study
Table 1. Overview of strains used in this study. *[-SP]: constructs cloned without sequence coding for the 
putative signal peptide (aa 1–18)].
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cloned into the pBH1 vector yielding in pER11 (primers see Table 2). To generate pCL13, L. pneumophila Corby 
plaD was cloned into the pBCKS vector yielding in pCL7 (primers see Table 2). After the digestion of pCL7 
with HpaI, the Hygr-gene cassette was cloned into the vector yielding in pCL13 (primers see Table 2). Knockout 
mutants were generated by natural transformation and homologous recombination29,53. PCR was used to examine 
Gentr and Hygr Legionella for the respective mutation.
Preparations of culture supernatants and cell lysates. For assessment of hydrolytic activities, bacteria 
were harvested at the end of exponential growth (if not stated otherwise at an OD600 of about 4). Culture superna-
tants were obtained by centrifugation for 5 min at 5000 g and in some instances were subsequently concentrated 
by ultra-filtration with an exclusion size of 10 kDa. Cell lysates were produced as described previously29,54. Culture 
supernatants and cell lysates were tested immediately for enzymatic activities.
Purification of recombinant ProA. Recombinant periplasmic ProA was isolated by osmotic shock55 from 
E. coli BL21(pCL15) and subsequent anion exchange chromatography as described before30.
Overexpression of recombinant Strep-PlaA, Strep-PlaA variants, and Strep-PlaD. For expres-
sion of recombinant Strep-PlaA (from pCL119), Strep-PlaA variants (from pCL126-127) and Strep-PlaD (from 
pSB2), E. coli BL21 cultures were grown at 37 °C to an OD600 = 0.8, induced with 0.1 mM IPTG and transferred to 
18 °C for 16-17 h. For the purification of Strep-PlaA, Strep-PlaA variants and Strep-PlaD, the cell pellet was col-
lected and resuspended in 100 mM Tris-HCl pH 8.0, containing 100 mM NaCl and 1 mM EDTA. Homogenization 
was performed by Emulsi Flex C3 (Avestin) applying 25,000 to 30,000 psi. The soluble fraction was isolated by 
centrifugation at 13,000 g and 4 °C for 60 min. Strep-PlaA and variants were purified using a Strep-Tactin® 
Superflow® high capacity resin (IBA) according to the manufacturer’s instructions.
Assays for lipolytic activities. Lipolytic (PLA, LPLA, lipase, acyltransferase/GCAT) activities were 
detected as described previously28,29,56 by using the lipid substrates 1-monopalmitoyllyso-phosphatidylcholine 
(LPC), 1—mono-palmitoyllysophosphatidylglycerol (LPG), 1-monopalmitoylglycerol (MPG), monopalmitoylly-
sophosphatidylethanolamine (LPE), dipalmitoylphosphatidylserine (PS), dipalmitoylphosphatidylethanol-amine 
(PE), 1,2—dipalmitoylphosphatidyl-glycerol (PG), 1,2-dipalmitoylphosphatidylcholine (PC) and cholesterol. In 
brief, 25 ng Strep-PlaA, Strep-PlaA-variants or 25 µl E. coli cell lysates were incubated with the lipid suspension 
and with or without 3.5 mUnit ProA or 25 µl supernatant from L. pneumophila plaACD- in a total reaction volume 
of 50 µl. For GCAT activity the reaction mix was doubled and cholesterol was added. All lipids, including stand-
ards for thin layer chromatography (TLC) were obtained from Sigma Chemicals or Avanti Polar Lipids. Detection 
of reaction products, such as free fatty acids and sterol esters, was performed by lipid extraction and subsequent 
TLC or by quantitative detection of free fatty acids as described earlier28,29.
Plasmid Gene Tag Primer name Primer sequence
pCL119 plaACorby (-SP) N-term Strep-Tag
plaA-SP_SacI_fw 5′-TAGAGCTCTATGACACCACTTAATAACATAG-3′
plaA-BamHI_rv 5′-TAGGATCCTTAATTCTCGGCGAA-3′
pCL121 plaACorby S30N (-SP) N-term Strep-Tag
PlaA_S30N_fw 5′-GTATTTGGTGATAATTTGTCGGATAACGG-3′
PlaA_S30N_rv 5′-CCGTTATCCGACAAATTATCACCAAATAC-3′
pCL122 plaACorby D279N (-SP) N-term Strep-Tag
PlaA_D279N_fw 5′-GGTTATTTGTTTTTTAATTTGGTTCATCCGACA-3′
PlaA_D279N_rv 5′-TGTCGGATGAACCAAATTAAAAAACAAATAACC-3′
pCL123 plaACorby H282N (-SP) N-term Strep-Tag
PlaA_H282N_fw 5′-TTTGATTTGGTTAATCCGACAGCGTTG-3′
PlaA_H282N_rv 5′-CAACGCTGTCGGATTAACCAAATCAAA-3′
pCL126 plaACorby ΔAA248-67 (-SP) N-term Strep-Tag
PlaA_Del267_fw 5′-ACAGAAAGCGCATGTGATGGT-3′
PlaA_Del248_rv 5′-TATCGAAAAGGAGCAAGTACCTGT-3′
pCL127 plaACorby S30N ΔAA248-67 (-SP) N-term Strep-Tag
PlaA_S30N_fw 5′-GTATTTGGTGATAATTTGTCGGATAACGG-3′
PlaA_S30N_rv 5′-CCGTTATCCGACAAATTATCACCAAATAC-3′
pCL7 PplaD plaDCorby PromD270_SacI 5′-GAGAGCTCTCCGTGCTCTTGCTGATA-3′
PlaD_r_XhoI 5′-GACTCGAGATTAAGTTAGGATTTCGTT-3′
pCL13 HygR Hyg-HpaI-fw 5′-AATTTAGTTAACATGACACAAGAATCCCTG-3′
Hyg-HpaI-rv 5′-AATTTAGTTAACTCAGGCGCCGGGGGC-3′
pER11 GentR BamH_Gent1 5′-AAGGATCCGACGCACACCGTGGAAA-3′
HindGent2 5′-TCGGAAGCTTGCGGCGTTGTGACAATTT-3′
pSB2 plaDCorby N-term Strep-Tag
PlaD_SacI_fw 5′-ATGAGCTCAATGGCCCAAAAA-3′
PlaD_BamHI_rv 5′-ATGGATCCTCAGGTAAATTTAAC-3′
pMH41 plaACorby E266N L267N
PlaA_E266N_L267N_fw 5′-TCTGTGAAGCCAAATAATACAGAAAGCGCA-3′
PlaA_E266N_L267N_rv 5′-TGCGCTTTCTGTATTATTTGGCTTCACAGA-3′
Table 2. Overview of primers used in this study.
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Processing of recombinant PlaA by recombinant ProA. 250 ng Strep-PlaA or Strep-PlaA E266N 
L267N was incubated with and without 0.5 mU recombinant ProA for 10 min, 1 h, 3 h, and 5 h. Afterwards, the 
samples were examined by Western Blot analysis using primary polyclonal rabbit antibody against PlaA and 
monoclonal HRP-conjugated mouse StrepMAB-Classic antibody (IBA) against Strep-Tag.
Western Blot analysis. Samples were separated on a 12.5% SDS-polyacrylamide gel57. Proteins were trans-
ferred to a nitrocellulose membrane. Primary polyclonal rabbit antibodies against PlaA, PlaD (generated by 
BioGenes against recombinant expressed and purified PlaA and PlaD) and PlaC30 were added at a dilution of 
1:1000. α-rabbit linked to G-horseradish peroxidase (Sigma) was used as secondary antibody diluted 1:10,000. 
For detection of the Strep-Tag the monoclonal mouse StrepMAB-Classic antibody (IBA) was used at a dilution of 
1:5000. Proteins were detected by chemiluminescence (ECL Kit; Amersham).
Determination of the ProA cleavage site within PlaA by mass spectrometry. Sample preparation: 
5 µg Strep-PlaA was incubated with and without 5mU ProA for 5, 10 and 30 min. The reaction mix was stopped 
by the addition of 1% SDS and 5 min at 95 °C. The protein was precipitated by 4 volumes of pre-cooled acetone 
for 1 h at −20 °C. The dried protein pellets were resuspended in 1 M urea, 100 mM Tris⋅Cl, pH 8.5 and digested 
for 16 h at 37 °C using Trypsin Gold, mass spectrometry grade (Promega, Fitchburg, WI, USA) at a protein/
enzyme ratio of 50:1. Peptides were reduced and alkylated in 10 mM Tris(2-carboxyethyl)phosphine and 40 mM 
2-chloroacetamide at 99 °C for 5 min and further desalted using 200 µL StageTips packed with one Empore™ SPE 
Disk C18 (3 M Purification, Inc., Lexington, USA)58.
nLC-MS/MS: peptides were analyzed on an EASY-nanoLC 1200 (Thermo Fisher Scientific, Bremen, Germany) 
coupled online to a Q Exactive™ Plus mass spectrometer (Thermo Fisher Scientific, Bremen, Germany). 100 ng 
peptides were loaded on a Acclaim™ PepMap™ trap column (20 mm × 75 μm i.d., 100 Å, C18, 3 μm; Thermo 
Fisher Scientific, Bremen, Germany) at a flow rate of 3 µL/min for 5 min and were subsequently separated on a 
50 cm Acclaim™ PepMap™ column (75 μm i.d., 100 Å C18, 2 μm; Thermo Fisher Scientific, Bremen, Germany) 
using a linear 70 min gradient of 2 to 50% acetonitrile in 0.1% formic acid at 200 nL/min flow rate. Column 
temperature was kept at 60 °C using a butterfly heater (Phoenix S&T, Chester, PA, USA). The Q Exactive™ Plus 
was operated in a data-dependent manner in the m/z range of 300–1,650 with a resolution of 70,000 using an 
automatic gain control (AGC) target value of 5 × 105 with a maximum injection time of 50 ms. Up to the 12 
most intense 2 + - 6 + charged ions were selected for higher-energy c-trap dissociation (HCD) with a normal-
ized collision energy of 25%. Fragment spectra were recorded at an isolation width of 1.5 Th and a resolution of 
17,500@200 m/z using an AGC target value of 1 × 105 with a maximum injection time of 110 ms. The minimum 
MS² target value was set to 1 × 104. Once fragmented, peaks were dynamically excluded from precursor selec-
tion for 30 s within a 10 ppm window. Peptides were ionized using electrospray with a stainless steel emitter, I.D. 
30 µm, (Proxeon, Odense, Denmark) at a spray voltage of 2.1 kV and a heated capillary temperature of 275 °C.
Data analysis. The mass spectra were analyzed using MaxQuant (Version 1.5.1.2)59. At first, parent ion 
masses were recalibrated using the ‘software lock mass’ option60 before the MS² spectra were searched using the 
Andromeda algorithm against the ProA and PlaA sequences as well as 245 entries of the cRAP database (http://
www.thegpm.org/crap/). Spectra were searched with a tolerance of 4.5 ppm in MS1 and 20 ppm in HCD MS² 
mode, using semi-tryptic specificity (KR not P) and allowing up to one missed cleavage site. Cysteine carbami-
domethylation was set as a fixed modification and methionine oxidation as a variable modification. The false 
discovery rate was set to 1% for peptide and 1% protein identifications. Identifications were transferred between 
samples using the ‘match between run’ option within a match window of 0.7 min and an alignment window of 
20 min. The statistical analysis of the MaxQuant results was done in Perseus (Version 1.5.0.31)61. At first, reverse 
peptide hits and contaminants were removed. Semi-tryptic peptides of PlaA with no intensities in the PlaA-only 
control are potential cleavage sites of ProA and were visualized in a heatmap based on their intensity values in 
the peptides.txt file.
Figure preparation. Figures were prepared with Microsoft Power Point 2010. All images, symbols and fonts 
within the figures are acquired from Microsoft Power Point 2010. Western Blots and TLCs were labelled and 
processed with Adobe Photoshop CS6. Graphs included in the Figures are visualized by Microsoft Exel 2010.
Data Availability. All data generated or analysed during this study are included in this published article or 
in the supplementary information (Figs S1–4 and Table S1).
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